Uttarakhand Govt Suspends Licences Of 14 Products Sold By Patanjali Ayurved Citing Misleading Advertisements


(MENAFN- Live Mint) "The drug regulator of Uttarakhand has suspended the manufacturing licences of 14 products made by Baba Ramdev's Patanjali Ayurved citing misleading advertisements about their efficacy, a notification dated April 24 showed Uttarakhand government's order has not been made public yet licences have been put on hold for repeatedly publishing misleading advertisements about the effectiveness of these medications, the government order showed Supreme Court has in recent weeks repeatedly criticised self-styled yoga guru and Patanjali Ayurved co-founder Ramdev for not complying with its directives to stop misleading advertisements of some of his products apex court will be hearing Patanjali's case on Tuesday, April 30, to determine whether to press contempt charges against Ramdev or not read: 'Baba Ramdev crossed red line, unfortunate was...': IMA president tells why it took on PatanjaliEarlier today, Indian Medical Association (IMA) president Dr RV Asokan explained why the doctors' body dragged Patanjali to court saying Ramdev“crossed a red line” when he claimed he could cure COVID-19 and at the same time maligned modern medicine.
In an interview with news agency PTI, Asokan said Ramdev went against the medical profession by saying \"modern medicine is a stupid and bankrupt science\".The Supreme Court recently heard the IMA's 2022 plea alleging a smear campaign against the COVID vaccination drive and modern systems of medicine.
In a 2021 video, Ramdev was allegedly heard saying, \"Allopathy is a stupid science and medicines such as Remdesivir, Fabiflu, and other drugs approved by the Drugs Controller General of India have failed to treat COVID-19 patients.\"
His remarks caused massive outrage and the IMA sent a legal notice to him court had asked Ramdev, his aide Acharya Balakrishnan and Patanjali Ayurved Ltd last month to issue a public apology for not following its orders on misleading ads a hearing on April 23, the court also came down heavily on the petitioner, the IMA, stating that its members also engage in recommending unnecessary and expensive medicines. It pointed out several complaints alleging unethical conduct of the IMA.(With agency inputs)

MENAFN29042024007365015876ID1108153369


Live Mint

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.